. The records of all patients were reviewed who underwent
or less in diameter from 1980 through 1999.
Results. The study included 100 patients (56 men and 44 women)
with a median age of 67 years (range 43 to 84 years). Lobectomy
was performed in 71 patients, bilobectomy in 4, segmentectomy
in 12, and wedge excision in 13.
Ninety-four patients had complete
mediastinal lymph node dissection. The cancer was an adenocarcinoma
in 48 patients, squamous cell carcinoma in 26, bronchioloalveolar
carcinoma in 19, large cell carcinoma in 4, adenosquamous cell
carcinoma in 2, and undifferentiated in 1. Tumor diameter ranged
from 3 to 10 mm. Seven patients had lymph node metastases (N
1,
5 patients; N
2, 2 patients). Postsurgical stage was IA in 92
patients, IB in 1, IIA in 5, and IIIA in 2. There were four
operative deaths.
Follow-up was complete in all patients and
ranged from 4 to 214 months (median 43 months). Eighteen patients
(18.0%) developed recurrent lung cancer. Overall
and lung cancer-specific 5−year survivals were 64.1% and 85.4%, respectively. Patients
who underwent lobectomy had significantly better survival and
fewer recurrences than patients who had wedge excision or segmentectomy
(
p = 0.04).
Conclusions. Because recurrent cancer and lymph node metastasis can occur in patients with non–small cell lung cancers 1 cm or less in size, lobectomy with lymph node dissection is warranted when medically possible.